Sun Pharmaceutical Industries Ltd. — Capital/Financing Update 2021

Mar 31, 2021

Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com CIN: L24230GJ1993PLC019050

==> picture [75 x 83] intentionally omitted <==

Date: 31.03.2021

To, National Stock Exchange of India Ltd, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051.

Scrip Name: SUNPHARMA

BSE Ltd., Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 524715

Dear Sir/ Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In furtherance to our intimation to the stock exchanges on 25[th] March 2021, that one of the wholly owned Indian subsidiary of Sun Pharmaceutical Industries Limited has subscribed to partnership interest to the extent of 20% in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), we hereby intimate that post admission of 3 new partners on 30[th] March 2021, in ABCD Technologies LLP, the partnership interest of our wholly owned Indian subsidiary in ABCD Technologies LLP now stands revised at 12.5% entitling 12.5% share of profit/ loss and voting rights.

This is for your information and dissemination.

Thanking you,

Yours faithfully,

For Sun Pharmaceutical Industries Limited

Ashok Digitally signed by Ashok Indulal Indulal Bhuta Date: 2021.03.31 Bhuta 19:27:28 +05'30'

[Ashok Bhuta] Compliance Officer

Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives.